نتائج البحث

A SONAR report on Nirmatrelvir/ritonavir-associated rebound COVID-19: Using new databases for evaluating new diseases.

• Authors : Bennett CL; Department of Southern Network on Adverse Reactions (SONAR), University of South Carolina, Columbia, South Carolina, United States of America.; Clinical Pharmacy and Outcomes Sciences, College of Pharmacy, University of South Carolina, Columbia, South Carolina, United States of America.

Subjects: Ritonavir*/Ritonavir*/Ritonavir*/therapeutic use ; Ritonavir*/Ritonavir*/Ritonavir*/adverse effects ; COVID-19 Drug Treatment*

• Source: PloS one [PLoS One] 2024 Sep 25; Vol. 19 (9), pp. e0308205. Date of Electronic Publication: 2024 Sep 25 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

Nirmatrelvir/ritonavir or Molnupiravir for treatment of non-hospitalized patients with COVID-19 at risk of disease progression.

• Authors : Butt AA; VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, United States of America.; Weill Cornell Medicine, New York, New York, United States of America.

Subjects: Ritonavir*/Ritonavir*/Ritonavir*/therapeutic use ; Hydroxylamines*/Hydroxylamines*/Hydroxylamines*/therapeutic use ; Disease Progression*

• Source: PloS one [PLoS One] 2024 Jun 06; Vol. 19 (6), pp. e0298254. Date of Electronic Publication: 2024 Jun 06 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

تفاصيل العنوان

Factors associated with the acceptability of Lopinavir/Ritonavir formulations among children living with HIV/AIDS attending care and treatment clinics in Mbeya and Mwanza, Tanzania.

• Authors : Jiwa, Nadiya Alnoor¹ (AUTHOR) ; Ketang'enyi, Eunice¹ (AUTHOR); Nganyanyuka, Kapongola¹ (AUTHOR)

Subjects: *HIV-positive children; *HIV; *RITONAVIRMWANZA (Tanzania)

• Source: PLoS ONE. 1/2/2024, Vol. 19 Issue 1, p1-10. 10p.

تفاصيل العنوان

Darunavir-cobicistat versus lopinavir-ritonavir in the treatment of COVID-19 infection (DOLCI): A multicenter observational study.

• Authors : Elmekaty, Eman Zeyad I.¹ (AUTHOR) ; Alibrahim, Rim¹ (AUTHOR); Hassanin, Rania¹ (AUTHOR)

Subjects: *RITONAVIR; *COVID-19; *COVID-19 treatmentQATAR

• Source: PLoS ONE. 5/4/2022, Vol. 17 Issue 5, p1-14. 14p.

تفاصيل العنوان

Combination of (interferon beta-1b, lopinavir/ritonavir and ribavirin) versus favipiravir in hospitalized patients with non-critical COVID-19: A cohort study.

• Authors : A. Malhani, Areej¹ (AUTHOR); A. Enani, Mushira² (AUTHOR); Saheb Sharif-Askari, Fatemeh³ (AUTHOR)

Subjects: *RITONAVIR; *RIBAVIRIN; *INTERFERON beta 1b

• Source: PLoS ONE. 6/10/2021, Vol. 16 Issue 6, p1-16. 16p.

تفاصيل العنوان

Therapy with lopinavir/ritonavir and hydroxychloroquine is associated with acute kidney injury in COVID-19 patients.

• Authors : Schneider, Johanna¹ (AUTHOR) ; Jaenigen, Bernd² (AUTHOR); Wagner, Dirk³ (AUTHOR)

Subjects: *COVID-19; *ACUTE kidney failure; *COVID-19 treatment

• Source: PLoS ONE. 5/11/2021, Vol. 16 Issue 5, p1-14. 14p.

تفاصيل العنوان

Quality assessment of oral antimalarial and antiretroviral medicines used by public health systems in Sahel countries.

• Authors : Cáceres-Pérez, Amor R.^1,2,3 (AUTHOR); Suárez-González, Javier^1,3 (AUTHOR) ; Santoveña-Estévez, Ana^1,3 (AUTHOR)

Subjects: *ANTIMALARIALS; *RITONAVIR; *HIV infectionsSAHEL

• Source: PLoS ONE. 5/9/2024, Vol. 19 Issue 5, p1-19. 19p.

تفاصيل العنوان

A retrospective cohort study of prescribing outcomes in outpatients treated with nirmatrelvir–Ritonavir for COVID-19 in an interdisciplinary community clinic.

• Authors : Leung, Valerie¹ (AUTHOR); Gill, Suzanne¹ (AUTHOR); Llanes, Andrea¹ (AUTHOR)

Subjects: *DRUG prescribing; *TREATMENT effectiveness; *PATIENT complianceTORONTO (Ont.)

• Source: PLoS ONE. 10/19/2023, Vol. 18 Issue 10, p1-11. 11p.

تفاصيل العنوان

Effectiveness of nirmatrelvir-ritonavir for the treatment of patients with mild to moderate COVID-19 and at high risk of hospitalization: Systematic review and meta-analyses of observational studies.

• Authors : Souza, Kathiaja Miranda¹ (AUTHOR); Carrasco, Gabriela² (AUTHOR) ; Rojas-Cortés, Robin³ (AUTHOR)

Subjects: *SCIENTIFIC observation; *COVID-19; *HOSPITAL care

• Source: PLoS ONE. 10/12/2023, Vol. 18 Issue 10, p1-23. 23p.

تفاصيل العنوان

Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19.

• Authors : Lowe, David M.^1,2 (AUTHOR) ; Brown, Li-An K.¹ (AUTHOR); Chowdhury, Kashfia³ (AUTHOR)

• Source: PLoS Medicine. 10/19/2022, Vol. 19 Issue 10, p1-20. 20p. 1 Diagram, 5 Charts, 3 Graphs.

تفاصيل العنوان